Project Details
Description
The aim of this project is to significantly advance upon ongoing efforts in understanding drug-induced cardiotoxicity not only at the single cell level but in a multicellular model that may better reflect the cellular microenvironment of the heart. Extending studies to assess the metabolite changes in the multicellular environment in response to cancer therapeutics may reveal events integral to toxicity which may lead to new knowledge to develop ways to minimise or prevent cellular toxicity in the cardiac niche.
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/19 → 28/02/22 |
Keywords
- GPCRs
- Cardiovascular
- Pharmacology
- Mass Spectrometry
- Toxicity
- Cancer Therapeutics
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
Investigating interplay between thrombin receptors and the molecular mechanism that lead to cancer therapy-associated platelet dysfunction
Cunningham, M. R. (Principal Investigator) & Sawyers, L. (Researcher)
1/10/18 → 29/04/19
Project: Research
-
Invited Talk - Understanding cellular and molecular mechanisms of anthracycline cardiotoxicity
Cunningham, M. R. (Speaker)
8 Feb 2022Activity: Talk or Presentation › Invited talk
-
Novel off-target effects of doxorubicin on cardiovascular gap-junctional proteins
Veerman, B. (Speaker), McMullen, C. (Contributor), Rattray, Z. (Contributor), Johnston, B. (Contributor), Dempsie, Y. (Contributor), Martin, P. E. M. (Contributor), Currie, S. (Contributor) & Cunningham, M. R. (Contributor)
5 Feb 2021Activity: Talk or Presentation › Oral presentation
-
P011 - Endothelial connexin-43 dysregulation in response to the anthracycline doxorubicin
Veerman, B. (Speaker), Dempsie, Y. (Contributor), Martin, P. E. M. (Contributor), Rattray, Z. (Contributor), Johnston, B. (Contributor), Currie, S. (Contributor) & Cunningham, M. R. (Contributor)
14 Dec 2020Activity: Talk or Presentation › Oral presentation